Cost-effectiveness of empagliflozin as a treatment for heart failure with reduced ejection fraction: an analysis from the Chinese healthcare perspective

Xiaohui Lin, Minhua Lin, Maobai Liu, Weiying Huang, Xuekun Nie, Zichun Chen, Bin Zheng